# Daniel Sem

> Daniel Sem is a seed investor at Talents Fund backing Health Care. See 1 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: Angel Investor
- Fund: Talents Fund
- Location: Milwaukee, United States
- Total investments: 1
- Last investment: Jul 2026
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/daniel-s-sem

Daniel Sem is a seed investor at Talents Fund in Milwaukee focused on Health Care and Pharmaceutical. Dr. Sem is also Dean and Professor of Business, Professor of Pharmaceutical Sciences, and Director of Technology Transfer at Concordia University Wisconsin. He also serves on the editorial board of PLoS One Life Sciences, the Board of Directors for the BBB, and for Ozaukee County Economic Development Corp. Dr. Sem has over 20 years of experience indrug discovery and development and has over 60 papers and 10 issued patents. He co-founded two drug discovery and development companies (Triad and AviMed) and one social venture (Bridge to Cures) before Retham. He served as VP for Biophysics at Triad Therapeutics, where he developed a platform technology for designing focused combinatorial libraries targeting kinases and dehydrogenases. He co-founded Triad Therapeutics based on technology he developed and patented, and he assisted in securing two rounds of venture financing, totaling over $40 million. Triad was voted one of the top 10 biotech startups in the U.S. in 2001 by Drug Discovery Today, and licensed kinase drug leads to Novartis for up to $60 million. Dr. Sem received his B.S. in Chemistry from UW-Milwaukee, his Ph.D. from UW-Madison in Biochemistry, and his MBA and JD degrees from Marquette University.

## Contacts

5 contacts available for Daniel Sem: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/daniel-sem-7184?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 1 | 100% |
| Pharmaceutical | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Estrigenix Therapeutics | Estrigenix Therapeutics, Inc. is a privately held pharmaceutical company focused on developing the next generation of innovative therapies to improve menopausal women's mental health. Estrigenix Therapeutics was formed in 2018 to improve women’s health, focusing initially on the physical and mental effects of menopause. | $2M | Seed | Jul 21, 2026 | https://www.estrigenix.com/ |

1 of 1 investments shown.

## About Talents Fund

VC Fund · Milwaukee, United States

Talents Fund is a seed-stage venture capital firm focused on investing in breakthrough life sciences and biotechnology startups.

3 contacts available at Talents Fund.

| Name | Title | Profile |
| --- | --- | --- |
| Curt Gielow | Co-Founder & Partner | — |
| Daniel Becker | Co-Founder , Partner & CFO | — |
| Daniel Sem | Founder & Managing Partner | — |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Daniel Sem invest in?

Daniel Sem invests primarily in Health Care and Pharmaceutical startups, most often at Seed stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Daniel Sem?

Public channels for Daniel Sem include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Daniel Sem last invest?

The most recent investment recorded for Daniel Sem closed in Jul 2026. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co